Biogen (BIIB)

Retained Earnings

$20.97B

Quarterly · Period ending: · USD

BIIB logo

BIIB Retained Earnings

Latest reported$20.97B
BIIB Quarterly Retained Earnings (-$53.80M → $20.97B)
High-resolution chart · PNG

BIIB retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
20,969,700,000
20,872,200,000
20,552,700,000
20,601,600,000
20,135,100,000
19,500,300,000
19,259,800,000
18,993,100,000
18,604,600,000
18,021,000,000
17,627,600,000
17,377,900,000
17,446,000,000
16,854,400,000
16,466,500,000
15,916,100,000
14,959,900,000
14,215,500,000
13,911,700,000
13,543,500,000
13,900,700,000
13,833,500,000
13,976,300,000
13,961,000,000
14,466,700,000
15,673,100,000
16,455,400,000
17,065,200,000
16,182,800,000
17,026,700,000
16,257,000,000
16,944,100,000
15,499,500,000
17,334,600,000
15,810,400,000
16,107,700,000
14,881,700,000
14,781,200,000
15,071,600,000
15,030,000,000
14,229,100,000
13,179,300,000
12,208,400,000
11,999,358,000
11,033,736,000
10,106,460,000
9,283,919,000
8,400,455,000
7,543,597,000
6,829,091,000
6,349,135,000
5,891,829,000
5,404,213,000
4,913,543,000
4,486,794,000
4,194,551,000
3,796,154,000
3,409,308,000
3,106,761,000
2,806,523,000
2,454,848,000
2,166,813,000
1,872,481,000
1,646,852,000
1,405,340,000
1,131,523,000
1,068,890,000
781,321,000
516,632,000
388,019,000
270,180,000
75,361,000
-103,137,000
-199,204,000
-352,169,000
-553,080,000
-666,955,000
-821,215,000
-860,827,000
-954,991,000
-1,104,681,000
-928,178,000
-1,021,644,000
-802,311,000
-793,384,000
-808,423,000
-801,094,000
-744,499,000
-725,516,000
-653,116,000
-611,921,000
957,484,000
913,296,000
892,458,000
838,756,000
812,131,000
780,601,000
754,832,000
705,893,000
667,965,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.